Azermai, M. et al. (2012). Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Research Reviews, 11, 78–86.
Ballard, C. and Corbett, A. (2013). Agitation and aggression in people with Alzheimer's disease. Current Opinion in Psychiatry, 26, 252–259.
Barnes, T. R., Banerjee, S., Collins, N., Treloar, A., McIntyre, S. M. and Paton, C. (2012). Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. British Journal of Psychiatry, 201, 221–226.
Dorsey, E. R. et al. (2010). Impact of FDA black box advisory on antipsychotic medication use. Archives of Internal Medicine, 170, 96–103.
Gallini, A. et al. (2014). Trends in use of antipsychotics in elderly patients with dementia: impact of national safety warnings. European Neuropsychopharmacology, 24, 95–104.
Hosia-Randell, H. and Pitkala, K. (2005). Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs and Aging, 22, 793–800.
Hughes, C. P. et al. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566–572.
Johnell, K. and Fastbom, J. (2012). Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs and Aging, 29, 751–758.
Kales, H. C. et al. (2011). Trends in antipsychotic use in dementia 1999–2007. Archives of General Psychiatry, 68, 190–197.
Lawton, M. and Brody, E. M. (1970). Assessment of older people: self-maintaining and instrumental activities of daily living. Nursing Research, 19, 278.
Lyketsos, C. G. et al. (1999). The general medical health rating: a bedside global rating of medical comorbidity in patients with dementia. Journal of the American Geriatrics Society, 47, 487–491.
Mittal, V. et al. (2011). Review: risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence. American Journal of Alzheimer's Disease and other Dementias, 26, 10–17.
Mjørud, M. et al. (2014). Variables associated to quality of life among nursing home patients with dementia. Aging & Mental Health, 18, 1013–1021.
National Institute for Health and Clinical Excellence (NICE). Dementia: Supporting People With Dementia And Their Carers in Health And Social Care (Clinical Guidelines, CG42). NICE, 2006.
Nijk, R. M. et al. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485–493.
Nørgaard, A. et al. (2015). Time trends in antipsychotic drug use in patients with dementia: a nationwide study. Journal of Alzheimer's Disease, 49, 211–220.
Nygaard, H. A. et al. (2004). Not less but different: psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) study. Aging Clinical and Experimental Research, 16, 277–282.
O'Bryant, S. E. et al. (2008). Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas Alzheimer's research consortium study. Archives of Neurology, 65, 1091–1095.
Pitkala, K. et al. (2015). Eight-year trends in the use of opioids, other analgesics, and psychotropic medications among institutionalized older people in finland. Journal of the American Medical Directors Association, 10, 009.
Ruths, S. et al. (2013). Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts. International Journal of Geriatric Psychiatry, 28, 868–876.
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 294, 1934–1943.
Selbaek, G. and Engedal, K. (2012). Stability of the factor structure of the neuropsychiatric inventory in a 31-month follow-up study of a large sample of nursing-home patients with dementia. International Psychogeriatrics, 24, 62–73.
Selbaek, G. et al. (2014). The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. International Psychogeriatrics, 26, 81–91.
Selbeak, G., Kirkevold, Ø. and Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843–849.
Steinberg, M. and Lyketsos, C. G. (2012). Atypical antipsychotic use in patients with dementia: managing safety concerns. American Journal of Psychiatry, 169, 900–906.
Thomas, S. K. et al. (2013). The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis. Drug Safety, 36, 557–564.
Wang, P. S. et al. (2005). Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New England Journal of Medicine, 353, 2335–2341.
Wetzels, R. et al. (2010). Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. American Journal of Geriatric Psychiatry, 18, 1054–1065.
Wood, S. et al. (2000). The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. American Journal of Geriatric Psychiatry, 8, 75–83.